This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients” published in Blood Cells, Molecules, and Diseases in which APICES has collaborated in several tasks of the project. This means an extra motivation to all APICES team in order to give continuity to the implication we have in every project in which we collaborate. APICES is proud of the recognition of our work and deliveries and we want to thank Dr. Lozano and Amgen S.A. Spain for the opportunity they have given to APICES to appear in the publication acknowledgments, and congratulate them and the rest of collaborating investigators for their project success.
This retrospective, multicenter study was aimed to analyze the implementation of current recommendations in the standard practice of adult ITP patients, and how age may influence those changes. Data reveal that there is a preferential use of TPO-RAs in elderly ITP patients with fewer bleeding complications.
For more detailed information: A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients